Dr Peter Bloomfield is director of research at the Macular Society. He is a neuroscientist by background and his PhD from Imperial College London focused on human brain imaging to investigate biomarkers for the onset of psychosis. Over the last 15 years, he has conducted research across a range of medical and life sciences topics, from novel treatments for multiple sclerosis to mechanisms of memory. He has worked in academia, industry, and government, conducting research and developing technology solutions, as well as helping others to do so. He is a trustee of the Healthcare Quality Improvement Partnership who promote healthcare quality improvement through audit.